Luis De La Maza

Title: Innovations in Vaccination: The Contributions of Luis De La Maza

Introduction

Luis De La Maza is an accomplished inventor based in Irvine, CA. He has made significant contributions to the field of immunology, particularly in the development of vaccines against sexually transmitted pathogens. His innovative work has the potential to impact public health positively.

Latest Patents

Luis De La Maza holds a patent for "Methods and compositions for vaccinating a subject for a sexually transmitted pathogen." This patent describes a purified major outer membrane protein (MOMP) that has been observed to induce protection against genital and respiratory challenges in mice. The MOMP contains variable domains that are highly immunogenic, eliciting cross-serovar neutralizing monoclonal and polyclonal antibodies and T cell responses in both animal and human models. The patent outlines a method for vaccinating a subject using a recombinant porin that contains at least one antigenic variable domain. The variable domains are strategically inserted into the amino acid sequence of the porin at a position encoding a surface-exposed loop. Additionally, the vaccine includes an adjuvant that induces a Th1 response greater than a Th2 response.

Career Highlights

Throughout his career, Luis De La Maza has worked with prestigious institutions, including Tufts University and Boston Medical Center Corporation. His research has focused on developing innovative solutions to combat infectious diseases, particularly those that affect vulnerable populations.

Collaborations

Luis has collaborated with notable colleagues such as Paola Massari and Guillermo E Madico. These partnerships have enhanced his research and contributed to the advancement of vaccine development.

Conclusion

Luis De La Maza's work exemplifies the importance of innovation in the field of vaccination. His contributions have the potential to lead to significant advancements in public health and disease prevention.